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Abstract 
The kinetics of calcium pyrophosphate dihydrate 
(CPPD) crystal growth was studied by allowing calcium and 
pyrophosphate (PPi- 4) ions to diffuse through a denatured 
collagen matrix (biological grade gelatin) in the presence of 
either ferric or ferrous ions. Ferric and, to some extent, 
ferrous ions blocked the migration of the PPi- 4 diffusion 
gradient. This retardation in the [PPi-4] gradient led to 
numerous changes in the patterns of CPPD crystal 
formation. At the initial stages of crystal growth, the iron 
ions induced more crystal growth compared to control. At 
later incubation times, ferrous and ferric ions enhanced 
crystal growth at the expense of crystal nucleation. The 
presence of both ferrous and ferric ions resulted in the more 
rapid formation of the two crystals observed in vivo, triclinic 
CPPD and monoclinic CPPD. Further, both ferrous and 
ferric ions also reduced the solubility of the crystalline 
material in the broad diffuse band which formed when the 
Ca +2 and PPi- 4 gradients first met. In this system, the 
presence of either ferrous or ferric ions increased the amount 
of hydroxyproline included in the crystalline precipitates. 
Iron was also incorporated into the crystals, particularly into 
the triclinic CPPD and monoclinic CPPD crystals. 
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Introduction 
There is a high probability of an association between 
calcium pyrophosphate crystal deposition disease and 
hemochromatosis [18]. Nearly one half of patients with 
hemochromatosis have arthritis and half of these have 
radiographic evidence of chondrocalcinosis [4,5,7] . Iron 
itself may be directly related to the calcific deposits since 
calcium pyrophosphate crystal deposits have also been 
observed in patients with transfusion hemosiderosis [1,22]. 
Chondrocalcinosis also occurs in patients with hemophilia 
[10 ,12]. Pediatric exposure to iron seems to enhance its 
deleterious effects as evidenced by the more frequent 
occurrence of calcium pyrophosphate crystal deposition in 
hemochromatosis than in other iron overload syndromes 
[9,21] . Also, experimental iron loading of rabbits induced 
cartilage degeneration only when initiated early in life [2]. 
In ultrastuctural studies of synovial membranes in 
hemochromatosis, hemosiderin deposits were seen in each 
type of lining cell, but were most common in the Type B 
cells which are rich in rough endoplasmic reticulum [19]. 
Iron aggregrates were observed to be either membrane 
bound or free in the cytoplasm. However, calcium 
pyrophosphate dihydrate (CPPD) crystalline deposits were 
not located near either the ferritin or the hemosiderin 
particles. In a similar study on articular cartilage [20], iron 
was located within chondrocytes, and both apatite and CPPD 
crystals were identified in locations other than those 
proximal to ferritin particles. 
It is not clear how tissue bound iron affects the 
formation of CPPD crystals. In vitro studies have indicated 
that ferrous, but not ferric, ions inhibit some inorganic 
pyrophosphatases [16]. In an in vitro solution crystal 
growth study, ferric ions were shown to promote CPPD 
crystal growth at lower pyrophosphate (PPi-4) levels [8]. 
Studies in rabbits have shown that synovial hemosiderosis 
slows the metabolic clearance of radiolabelled CPPD crystals 
from joints by about 50% [ 17]. 
We have previously reported using calcium (Ca+2) 
and PPi-4 ionic diffusion through a denatured collagen 
(biological grade gelatin) matrix to induce CPPD crystal 
growth as a reproducible in vitro model system for CPPD 
deposition in cartilage [13-15] . We now report the use of 
this model system to study the effect of soluble iron on ca+ 2 
and PPi-4 ionic diffusion and on CPPD crystal nucleation 
and growth . 
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Materials and Methods 
Gel Preparation 
Gels were prepared as described previously [ 13]. 
Briefly, all glassware was washed, soaked in bleach for 24 
h, thoroughly rinsed in doubly-distilled water, and 
siliconized with an organo-silicone surfactant (Masil-1066-
D, Maser Chemicals, Gurnee, IL). Gelatin solutions (5% 
w/v) were prepared using biological grade gelatin, Bloom 
#275, (Fisher Scientific, Chicago, IL). Eighty percent of the 
dry weight of the gelatin was estimated to be collagen based 
on its hydroxyproline content [23] . The remaining 20% was 
determined to be a mixture of unidentified proteins and small 
peptides. The gelatin was found to contain only type I 
collagen by sodium dodecyl sulfate gel electrophoresis [3]. 
The commercially available gelatin is derived from porcine 
skin and contains all physiologic ions at approximately 25-
30% of their normal concentrations. The base levels of 
ca+2 = 0.5 mM, Mg+ = 0.1 mM, PO4 = 0.3 mM, and PPi-4 
< 0.01 mM in the 5% gelatin solution were determined by 
atomic absorption and spectrophotometric assays as detailed 
below. 
Study I. The effect of excess calcium ions as a control 
This study was previously published [13), but serves 
as one of the controls for the current study, and is therefore 
repeated here. Gels were poured in 20 identical 200 x 22 
mm test tubes in four equal partitions of 15 ml each . The 
lowest partition contained gelatin and 10 mM sodium 
pyrophosphate (Fisher Chemical Co, Chicago, IL), the 
middle two partitions (one-half of the total volume) 
contained gelatin alone, and the upper partition contained 
gelatin and 50 mM calcium acetate (Fisher Chemical Co, 
Chicago, IL). Each partition was prepared immediately 
before use, adjusted to pH= 7.0 with either NaOH or acetic 
acid, layered separately into the test tubes while hot, and 
then cooled in an ice bath. The length of the ion free band 
was 8 cm. Sodium azide, 0.3 M, was added to all solutions 
since fungal growth occurred if the azide concentration was 
below 0.25 M. This had no effect on crystal growth. 
The tubes were allowed to incubate for 
predetermined times at 23° C; the gels melted above 30° C. 
Duplicate tubes (which were morphologically identical in all 
cases) were harvested at weeks 1, 2, 3, 4, 5, 6, 7, 8, 10, 
and 12 by removing the entire gelatin cylinder intact from 
the test tube. Each cylinder was sliced into 8 layers, each 
being 2 cm long, and the crystals removed as described 
below. Crystals grew in the lower 5 layers which were 
pooled from the duplicate tubes and saved for further 
analysis. 
Study II. The effect of ferric ions with excess calcium ions 
Gels were prepared as described for Study I, with 
the exception that five partitions were poured. The lowest 
partition was 15 ml of gelatin plus 10 mM pyrophosphate, 
the next partition was 5 ml of ion-free gelatin, the next was 
20 ml of gelatin plus 0 .5 mM FeCl3 , followed by another 5 
ml of ion-free gelatin, and finally 15 ml of 50 mM calcium 
acetate. Gel tubes were harvested as described for Study I. 
Study III. The effect of excess pyrophosphate ions as a 
control 
--This study was also previously published [13], but 
serves as one of the controls for the current study, and is 
therefore repeated here. Gels were poured in 15 identical 
100 x 11 mm test tubes in four equal partitions of 2.5 ml 
each. The lowest partition contained 50 mM sodium 
pyrophosphate, the middle two partitions were again ion-
free, and the upper partition contained 50 mM CaCh. All 
solutions were prepared as described above except that they 
contained 0.4 M sodium azide. The length of the ion-free 
zone was 4.0 cm. 
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The gel tubes were harvested on days 4, 6, 7, 10, 
12, 14, 19, 26, 33, 40, 47, 55, 69, 97, 125, and 153. The 
entire gelatin cylinder was removed as described above, 
sliced into 7 equal layers which were saved for further 
analysis. 
Studies IV and V. The effect of ferric and ferrous ions in the 
presence of excess pyrophosphate ions 
Gels were prepared as described for Study III, with 
the exception that five partitions were poured. The lowest 
partition was 2.5 ml of gelatin plus 50 mM pyrophosphate, 
the next partition was 2.0 ml of ion-free gelatin, the next was 
1.0 ml gelatin plus 0.02 mM FeCl3 for Study IV and 0.02 
mM FeCl2 for Study V, followed by another 2.0 ml of ion-
free gelatin, and finally 2.5 ml of gelatin plus 50 mM CaCl2. 
The gel tubes were harvested as described in Study III. 
Ci:ystal Characterization 
For all studies, the gelatin layers were melted at 
50°C, the final pH checked, and the crystalline material 
isolated by centrifugation, washed twice with 1 ml of wann 
doubly distilled water, and air-dried. All samples were 
characterized with high resolution X-ray powder diffraction 
using copper radiation at 15 mA and 45 kV using an XRD -5 
generator (General Electric, Milwaukee, WI) . Samples 
containing sufficient material were mounted on aluminum 
foil (Reynolds Wrap, Richmond, VA) for internal 
diffraction standardization and diffracted using a quartz 
crystal monochromated Guinier diffraction camera (Huber 
Instruments, Rimsting, West Germany) . Samples 
containing little material were mounted on Magic Transparent 
Tape (3M, Minneapolis, MN) and diffracted for 20 h using a 
quartz crystal monochromated Guinier camera (Philips 
Electronic Instruments, Mahwah, NJ) . For these samples, 
the image of the primary X-ray beam was used to 
standardize the diffraction maximum. Diffraction patterns 
were either measured or compared to those of known 
pyrophosphate structures [11]. The term amorphous was 
used if there was a significant amount of precipitate, yet no 
diffraction pattern was obtained . If a small amount of 
precipitate was observed with no diffraction pattern , the 
material was labeled unknown . It is possible that some of 
the material assigned "U" may in fact be amorphous. 
Representative samples were mounted on planchets, 
coated with carbon, and were characterized with scanning 
electron microscopy (Model 1200, Advanced Metals 
Research Corporation, Bedford, MA) . The 
calcium:phosphorus and iron:phosphorus ratios were 
determined using an energy dispersive analyzer (EEDSII EG 
and G Ortec, Oak Ridge, IL) . 
Pyrophosphate Concentration Determination . 
The pyrophosphate concentration was determined by 
a modification of the method of Fiske and SubbaRow [6] 
using test kits (Sigma Chemical Company, St. Louis, MO). 
An aliquot of each gel section (0.25 ml) was incubated with 
5.0 ml of 1.0 N HCl for 24 h to solubilize the gelatin and 
hydrolyze the pyrophosphate ions. It was necessary to use 
HCI in place of trichloroacetic acid in the gelatin system 
since it induced protein precipitation which scavenged both 
phosphate and pyrophosphate ions. Optical absorbance was 
determined at 660 nm on a Model 250 Spectrophotometer 
(Gilford Instruments, Oberlin, OH) and concentrations 
determined against known standards prepared in the 
presence of gelatin. Assays were done in triplicate with an 
average standard error of 0.005 mM. 
Calcium and Iron Concentration Determinations 
Calcium ion concentration was determined by atomic 
absorption analysis (Model AA-1475ABD , Varian 
Associates, Palo Alto, CA). A 0.30 ml aliquot of gel was 
diluted with a solution containing 1 % LaCl3 in 5% HCI 
according to standard procedures . Concentrations were 
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determined with a 1000 microgram/ml [Ca+ 2] standard in 
2% HCl (Aldrich Chemical, Milwaukee, WI) diluted as 
above. Determinations were done in triplicate; the average 
standard error was 0.05 mM. The magnesium concentration 
in the gel and the iron concentrations for Study II were 
determined using similar, standard techniques. 
Preparation of Ion Gradient Contour Plots 
The [Ca+2] was plotted as a function of tube position 
and time and then the plot was contoured. The [PPi-4] 
contour plot was constructed in the same manner and the two 
plots superimposed photographically. The crystals which 
had been identified at each tube position and time point were 
then added to the composite ionic gradient plots. The iron 
contour plot for Study II was constructed in a similar 
manner . 
Determination of Hydroxyproline Inside Crystalline Samples 
One ml of 1 N HCl was added to selected samples of 
crystalline precipitates. This dissolved a portion of all of the 
samples, however for the early (4 to approximately 7 days) 
samples, a fine net of material remained which was 
dissolved three days later after the addition of 0.5 ml of 5 N 
HC!. The pH of the solution was returned to 7 with NaOH. 
The total hydroxyproline concentration was then determined 
spectrophotometrically following standard procedures [23). 
The hydroxyproline concentration was determined singly on 
the entire sample due to its small size. 
Computer Sorts 
Each slice with its associated tube position, time, 
[Ca+2], [PPi-4], pH, and crystal type was entered into a data 
file. The data file was sorted according to these variables by 
the program CORLA TE written by the authors for an Eclipse 
S/230 (Data General, Boston, MA) . The program allows for 
nested sorts of up to 10 variables as well as for sorts holding 
up to 10 variables constant at input values . This program 
was used to determine the maximum and minimum [Ca+2], 
[PPi-4), and ion products associated with each crystal type. 
Results 
The diffusion of ca+ 2 and PPi -4 ions through the 
matrix environment provided by the biological gelatin leads 
to the formation of various crystallographic forms of calcium 
pyrophosphate crystals. These calcium pyrophosphate 
dimorphs nucleate, grow, dissolve, and transform over time. 
The experimental design has allowed for the kinetic analysis 
of these crystallization processes . The model system has 
y~elded the in vivo crystals, triclinic calcium pyrophosphate 
d1hydrate (t-CPPD) and monoclinic (m-CPPD) . In addition, 
the system has produced crystals of orthorhombic calcium 
pyrophosphate tetrahydrate (o-CPPT), two mixed ca+2fNa+ 
pyrophosphate salts, and amorphous calcium 
pyrophosphate. The crystal types will be denoted t-CPPD 
(t), m-CPPD (m), o-CPPT (o), C, D, and a, respectively; 
the nomenclature N indicates no crystal growth, and U 
indicates insufficient crystalline material which could not be 
identified using X-ray diffraction . 
The kinetics of the crystal growth process have been 
analyzed using ionic gradient maps of the changes in [Ca+2] 
and [PPi-4) as a function of time of incubation, of the crystal 
type formed, and of the specific position within the tube 
(Figures 1-6). The maximum and minimum [Ca+2] and 
[PPi-4), ion product, and time of formation for the various 
crystal types are shown for Studies I, II, III, IV, and V in 
Table 1. 
Study I 
As shown in Figure 1, the control with excess of 
Figure 1:. The kinetics of CPPD crystal growth in the 
presence of excess ca+2 (Study I, control for Study II). 
Both the [Ca+2] and [PPi-4] have been contoured at 1 mM 
increments, using dashed lines for [Ca+ 2], and solid lines 
for [PPi-4]. No contours are included for concentrations in 
excess of 10 mM for clarity . Only the lower 10 cm of gel 





























Neil S. Mandel, Paul B. Halverson, and Gretchen S. Mandel 
To.!2.!tl: Minimum and maximum [Ca+2], [PPi-4], ion product, and time of formation for the various crystal types along with 
the total number and frequency of occurrence as a percentage of the total number of observations . The overall minimum and 
maximum values for each study are presented as "total" . The ion product is expressed as [Ca+2]2 * [PPi-4], since the chemical 
formula for CPPD is Ca2P207. ND indicates not determined. 
# % [Ca+2] [PPi-4] [Ca +2 ]2* [PPi-4] TIME 
mM mM M3 days 
STUDY I (Control, Excess Ca+2, no added Fe) 
33 41 0.2 - 8.2 0.0 - 4.1 2.0xJ0-11 - l.lxJ0-7 28 - 84 
m 17 21 0.2 - 8.0 0.0 - 9.1 3.0xJ0-11 _ 1.0xJ0-8 7 - 84 
0 44 55 0.2 - 8.2 0.0 - 10.2 2.0xlo-11 - 6.5xJ0-7 7 - 84 
a 2 3 5.7 - 5.7 9.2 - 9.2 3.0xJ0-7 - 3.0xJ0-7 14 - 14 
N 30 38 ND ND ND 7 - 84 
total 80 0.3 - 8.20 0.0 - 10.2 2.0xJ0-11 - 6.5xJ0-7 7 - 84 
STUDY II (Excess Ca+ 2, FeCl3) 
11 14 4.7 - 10.6 0.0 - 3.2 9.0xJ0-11 - 6.lxJ0-8 14 - 84 
m 15 19 0.6 - 8.7 0.2 - 8.3 2.lxJ0-9 -6.lxJ0-8 7 - 84 
0 33 41 0.6 - 9.7 0.0 - 8.3 9.0xJ0-11 - 6.lxJ0-8 7 - 84 
u 4 5 0.5 - 9.1 1.6 - 5.2 6.5xJ0-8 - l.3x 10-7 21 - 28 
N 33 41 ND ND ND 7 - 84 
total 80 0.5 - 10.6 0.0 - 8.3 9.0x10-ll _ 1.3x10-7 7 - 84 
STUDY III (Control, Excess ppj-4, no added Fe) 
3 3 0.2 - 0.2 2.7 - 5.5 1.lxJ0-10 - 2.2x1Q-l0 97 - 125 
m 25 22 0.1 - 2.1 2.0 - 8.7 5.0xJ0-11 - 8.8xJ0-9 26 - 153 
0 51 46 0.1 - 7.1 0.0 - 9.3 5.0x10-l l - 3.9xJ0-8 4 - 153 
a 5 4 8.2 - 16.0 0.0 - 2.0 2.3xJO-IO - l.3xJ0-7 4 - 12 
u 3 3 0.3 - 0.5 4.6 - 13.3 6.lxJ0-10 - 2.lxJ0-9 14- 40 
N 29 44 0.1 - 31.7 0.0 - 30.7 1.0xJ0-11 - 2.9xJ0-7 1 - 153 
C 11 2 0.2 - 0.8 4.0 - 25 .8 1.6xJO-IO - 2.8xJ0-9 4 - 153 
D 23 5 0.2 - 0.8 1.5 - 29.9 1.lxJ0-10 - l.lxJ0-8 4 - 153 
total 112 0.1 - 31.7 0.0 - 30.7 1.0x 10-l l - l.3x 10-7 1 - 153 
STUDY IV (Excess PPi· 4, FeCl3) 
7 6 0.1 - 3.6 0.0 - 4.5 3.0xJ0-11 - 7.0xJ0-10 19 - 125 
m 19 17 0.1 - 7.2 0.0 - 4.7 1.0xJ0-11 - 4.lxJ0-9 10 - 153 
0 51 46 0.1 - 7.2 0.0 - 5.8 1.0xJ0-11 - 1.8xJ0-8 4 - 153 
a 6 5 0.2 - 14.8 0.0 - 29 .2 1.9xJO-IO - 7.3xJ0-9 4- 40 
u 6 5 0.1 - 0.2 1.4 - 6.0 2.0x10-ll _2.4x10-l0 26 - 153 
N 33 21 0.1 - 30.8 0.0 - 44.8 2.0xJ0-11 - 6.lxJ0-8 4 - 153 
C 6 4 0.1 - 0.4 4.0 - 30.3 4.0xJ0-11 - 2.7xJ0-9 4 - 125 
D 14 9 0.1 - 0.5 0.6 - 16.8 1.0x 10-l l - 1.0x 10-9 4 - 153 
total 112 0.1 - 30.8 0.0 - 44.8 1.0xJ0-11 - 6.lxJ0-8 4 - 153 
STUDY V (Excess PPi•4, FeCl2) 
13 12 0.1 - 0.6 3.1 - 6.2 4.0x 10- l l - 1.4x 10-9 33 - 153 
m 24 21 0.1 - 4.0 0.0 - 8.3 2.0xJ0-11 - 3.2xJ0-9 19 - 153 
0 55 49 0.1 - 8.2 0.0 - 26 .0 4.0x10-ll _9_1x10-9 4 - 153 
a 7 6 0.2 - 20.9 0.0 - 23.4 9.4xJ0-10 - 2.3xJ0-7 4- 12 
u 4 4 0.1 - 0.4 4.8 - 28.6 5.0xJ0-11 - 2.6x10-8 7 - 125 
N 33 29 0.1 - 28.9 0.0 - 34.9 5.0xJ0-11 - 5.lxJ0-7 4 - 153 
C 12 11 0.1 - 0.4 0.3 - 16.4 1.0xJ0-11 - 1.5xJ0-9 JO - 153 
D 16 14 0.1 - 0.5 1.5 - 26.0 6.0xJ0-11 - 2.3xJ0-9 4 - 153 
total 112 0.1 - 28.9 0.0 - 34.9 5.0xJ0-11 - 5.lx J0-7 4 - 153 
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ca+ 2, the variation in the calcium concentration has been 
contoured in 1 mM increments using dashed lines originating 
from the upper left of the plot (the top of the growth tube), 
and the PPi-4 concentrations have been contoured in 1 mM 
increments in solid lines originating from the right of the plot 
(the bottom of the tube). The contour levels for both ions 
were omitted when concentrations exceeded 10 mM. Only 
the lower 10 cm of gel are shown here since no crystals 
formed in the original calcium doped partition. 
The ca+2 and PPi-4 gradients migrate to the center of 
the tube within one week, interact at [Ca+2] = 3-7 mM and 
[PPi- 4) = 0.5-2 mM with the formation of crystal o-CPPT. 
Simultaneously, crystals of m-CPPD also formed in the 
PPi- 4 rich partitions. Crystal o-CPPT rapidly dissolved at 
two weeks with a commensurate burst of available PPi- 4. 
Amorphous calcium pyrophosphate formed at 2 weeks at the 
high [Ca+2] and [PPi-4) and converted to t-CPPD and o-
CPPT at 3-4 weeks. At 8 weeks when the ion 
concentrations had approached physiologic levels, the crystal 
types included t-CPPD, m-CPPD, and o-CPPT . From 
Table 1, the ion product varies over 4 orders of magnitude 
for the various crystals, except for amorphous . The range of 
ion products and maximum and minimum [Ca+2] and 
[PPi-4] for crystals t-CPPD, m-CPPD , and o-CPPT were 
nearly identical . 
Slll.c!ill 
As shown in Figure 2, the addition of ferric ions in 
the presence of excess calcium markedly alters the [PPi-4) 
gradient. Levels of 1 mM PPi-4 were not detectable within 
the ferric doped layers throughout the 12 weeks of the study. 
The [Ca+2] gradient remains virtually identical to that 
observed in Study I with some very small and probably not 
meaningful alterations. Crystal growth was also markedly 
affected by the pre sence of ferric ions. Although m-CPPD 
formed at 1 week in both the control (Study I) and in the 
ferric study, the position of crystal formation was different . 
In the control, m-CPPD crystals formed at 1 week in areas 
of the gel where [PPi-4) was 5 times greater than [Ca+2]. 
In the ferric study, m-CPPD crystals not only formed in 
areas of excess of PPi- 4, but they also formed in the ferric 
doped layers where the ca+ 2 ion concentration was 
approximately 8 mM and the PPi-4 levels were less than 
0.01 mM . By week 2, t-CPPD crystals had also appeared in 
the ferric doped layers, whereas in the control, the first 
appearance of t-CPPD crystal was week 4 in areas of excess 
PPi-4. 
Figure 3 shows the change in the [Fe+3] in Study II 
as a function of time, tube position, and crystal type formed . 
Contour levels were 0.01 mM and the contours with tick 
marks indicate boundary regions of decreased [Fe+3]. The 
initial formation of m-CPPD and t-CPPD crystals appears to 
have scavenged substantial amounts of ferric ion from the 
gels. When these crystals dissolved at week 4 (compare 
Figures 2 and 3), there was a release from <0.01 mM to 
>0.04 mM Fe+3. At week 6, t-CPPD reformed, again 
scavenging ferric ions. As these crystal dissolved at week 7, 
and new t-CPPD and m-CPPD reformed at week 8, there 
was again a release followed by scavenging of ferric ions . 
From Table 1, t-CPPD formed at 14 days rather than at 28 
days in the control. The minimum [Ca+ 2] for t-CPPD 
formation was 4.7 mM as opposed to 0.2 mM in the control. 
This is probably a result of the blockage of the PPi- 4 
gradient by the ferric ions, rather than a significant difference 
in concentration requirements. 
Table 2 details the Ca:P and Fe :P ratios for 
crystalline samples selected to be as representative as 
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Figure 2: The kinetics of crystal growth showing the effect 
of ferric ions in the presence of excess ca+2 (Study II). The 
ferric ions were added to the gel layers 4 and 5, which are 
between 6 - 10 cm. The contours are indicated as described 




































possible over the varied conditions observed in the gel. 
Clearly, the crystals that grew in the iron doped layers 
(layers 4 and 5) incorporated iron into their crystalline 
lattices . The amount of incorporated iron was approximately 
0.08% w/w . 
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Figure 3: For Study TI, a kinetic contour map of the changes 
in the [Fe+ 3] as a function of time, tube position, and crystal 
type formed. Contour levels are 0.01 mM and the contours 
with tick marks indicate boundary regions leading to 
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As shown in Figure 4, the control with excess of 
PPi- .4, th~ k\netic contour map (Figure 4a) of the ionic 
gradients md1cates that the crystal types formed include t-
CPPD, m-CPPD, o-C .PPT, a, u,. C, and D. Figure 4b 
shows the photographic progress10n of crystal fonnation 
during the 22 weeks of incubation . At high [Ca+2] and low 
[PPi-4], amorphous formed, was present for 2 weeks, and 
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Table 2: The Ca:P and Fe:P ratios for selected cryst als 
grown during Study II. Phosphorous is defined as 1. 
Layers 4 and 5 were doped with ferric ions . Standard 
deviations are given in parenthesis. 
Time Layer Ca:P Fe:P Crystal 
(days) 
7 4 1.04(0 .12) 0.03(0.01) m 
7 7-8 1.05(0 .11) 0.01(0.01) mo 
35 4-5 1.00(0.05) 0.04(0.01) 0 
49 4-5 1.10(0.09) 0.03(0.01) 0 
70 6 0 .99(0 .07) 0 .0 0 
84 4 0.92(0.09) 0 .04(0.00) to 
84 5 1.11(0.10) 0.0 to 
then transformed to o-CPPT. 0-CPPT crystallized in t e 
center of the tube, fonning the milky white band seen in 
Figure 4b and did not dissolve for 6 weeks . The layers 
towards the PPi-4 rich partition produced the two mixed 
ca+2fNa+ PPi-4 salts which prevailed throughout the study. 
Of note, is that in contrast to Study I where the ionic 
gradients had not reached equilibrium by 12 weeks, the 
excess of PPi-4 in Study III appears to have induced ionic 
equilibrium within the tube at 7 weeks . Also in contrast to 
Study I, there was relatively little t-CPPD fonned in Study 
III . Further, there was no crystal growth in the PPi- 4 rich 
partitions in the bottom of the tubes or in the calcium rich, 
upper section of the tubes until the [Ca+2] dropped below 10 
mM . From Table 1, the range in the ion products for the 
fonnation of t-CPPD and m-CPPD is narrower compared to 
Study I, and there were fewer occurrences of t-CPPD . 
Study IV 
As shown in Figure 5, for the effect of ferric ions in 
the presence of excess PPi-4, the kinetic contour map 
(Figure 5a) of the ionic gradients indicates that the crystal 
types formed parallel to those observed in Study III (the 
control for excess PPi- 4, Studies IV and V) . Figure Sb 
shows the photographic progression of crystal fonnation and 
dissolution over the 22 weeks of incubation. The first 
observation in comparison to Figure 4 (the excess PPi-4 
control) is that the PPi-4 ionic gradient did not break through 
the ferric doped layer until week 3, at which time the [PPi-4] 
probably reached a level sufficient to bind up all of the ferric 
ions . At week 2, the [PPi-4] in the ppj-4 rich layer dropped 
to 8 mM, whereas in the control at week 2, the [PPi-4] had 
only dropped to 20 mM . The amount of crystalline material 
formed by week 2 in the ferric doped system was 
significantly greater than in the control. Following week 3 
with the PPi--4 gradient crossing of the ferric ion barrier, the 
ca+ 2 and PPi- 4 gradients and the crystal types fonned are 
similar between the control and the ferric doped gels. Prior 
to week 3, the calcium rich layers were deprived of PPi-4 as 
compared to the control, and it is noteworthy that the 
amorphous materials formed in the control are not common 
in the ferric doped system. The formation of m-CPPD at 
day 10 and the formation of t-CPPD at day 19 in the ferric 
doped system significantly preceded the time of formation in 
the control (days 26 and 97, respectively). From the 
photographic composites (Figures 4b and 5b), the addition 
of ferric ions led to the formation of a broader diffuse band 
which maintained its structure for 2 additional weeks. Also, 
following the disappearance of the diffuse band, the ferric 
doped gel had fewer, yet larger crystalline masses, 



















Effect of Soluble Iron on CPPD Crystal Growth 
Fig:ure 4: The kinetics of CPPD crystal growth in the presence of excess PPi-4 (Study III, control 
for Studies IV and V). In Figure 4a, the contours are as described in Figure 1, except that both 
[Ca+2] and [PPi-4] were contoured in I mM increments up to 10 mM, above which the increments 
are 5 mM . The composite photographs monitoring the progressive changes in crystal growth are 
shown in Figure 4b. 
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Neil S. Mandel, Paul B. Halverson, and Gretchen S. Mandel 
Figure 5: The kinetics of CPPD crystal growth showing the effect of ferric ions in the presence of 
excess PPi-4 (Study IV) . In Figure 5a, the contours are as described in Figure 4. The composite 
photographs monitoring the progressive changes in crystal growth are shown in Figure 5b. 
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Effect of Soluble Iron on CPPD Crystal Growth 
Fi&ure 6: The kinetics of CPPD crystal growth showing the effect of ferrous ions in the presence 
of excess PPi- 4 (Study V). In Figure 6a, the contours are as described in Figure 4. The 
composite photographs monitoring the progressive changes in crystal growth are shown in Figure 
6b. 
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StudyV 
As shown in Figure 6, the presence of ferrous ions 
in the presence of excess PPi-4, the kinetic contour map 
(Figure 6a) indicates that the same crystal types formed as in 
Studies III and IV. Figure 6b is the photographic composite 
of the kinetics of crystal formation over the 22 weeks of 
incubation. The addition of ferrous ions, in comparison to 
ferric ions, had a less dramatic effect on the migration of the 
PPi-4 gradient . As in Study IV , there was a rapid 
precipitation of crystalline material at the ferrous ion doped 
layer as evidenced by the drop in [PPi-4] to 5 mM by week 
2. At the third week, some of the crystals which had grown 
in the PPi- 4 rich layers dissolved, raising the PPi- 4 
concentration in this region to 6 mM. This released PPi-4 
then migrated towards the ca+2 gradient. This same influx 
of fresh PPi-4 ions into the PPi-4 gradient, which resulted 
from the dissolution of material deposited in the PPi-4 rich 
layers at early time, was also observed in Study I and, to 
some extent, Study III . At the end of the study, there is 
more remaining PPi- 4 in the ferrous study (5-6 mM) 
compared to the ferric study (1-4 mM). The diffuse central 
band which formed in the ferrous ion layer remained longer 
in the ferrous study than in the ferric Study IV (week 14 
compared to week 8, respectively). In general, there are 
fewer particles in the ferrous study compared to the ferric 
study, but the sizes of the crystalline particles are 
comparable. 
Morphology 
The crystal growth morphologies for the three 
primary crystal products, t-CPPD, m-CPPD, and o-CPPT, 
were similar in all five studies. As shown in Figure 7a, the 
crystals in the control Study III had three morphologies . 
The most common growth morphology was geodes 
composed of needles radiating from a central point . These 
geodes were composed of crystals t-CPPD, m-CPPD , and 
o-CPPT . There were also feathery composites of crystals 
which were identified in other pure samples as being o-
CPPT. The least frequent crystal morphology was poorly 
shaped rods or broken plates. The primary crystal growth 
morphology noted for a sample of t-CPPD, m-CPPD, and o-
CPPT from Study I was individual needles [13] . As a 
representative sample, the growth morphology of a sample 
from Study V is shown in Figure 7b . This sample came 
from the ferrous doped layer at week 8 and contains t-
CPPD, m-CPPD, and o-CPPT. In addition to the crystal 
morphologies described for the control samples, there were 
rare occurrences of t-CPPD crystals with growth 
morphology paralleling that observed in vivo. 
Occluded collagen 
The amount of collagen, quantitated by 
hydroxyproline content, occluded into the crystals as they 
grew in the gelatin matrix is cited in Table 3. The total 
amount of crystalline material was quantitated by 
determining the [Ca+ 2] in the assay solutions. So as to 
normalize the amount of hydroxyproline per crystalline 
mass, the amount of hydroxyproline was divided by the 
[Ca+2] (Table 3). In the two control Studies I and III, there 
was significant collagen occlusion in the crystals grown at 
early times, however, there was no detectable collagen 
occlusion into crystals which grew at later time points after 
the initial crystals dissolved. The addition of either ferrous 
or ferric ions did not seem to change the level of collagen 
occlusion in the early crystals . However, the presence of 
both ferrous and ferric ions seemed to enhance the occlusion 
of collagen in the crystals which grew at later time points. 
1186 
Figure 7 : Scanning electron photomicrographs of 
representative crystalline samples . Figure 7a shows the 
growth morphologies of crystals t-CPPD , m-CPPD, and o-
CPPT in a sample taken from the control Study III at week 
18, layer 3. The effect of ferrous ions on the crystal growth 
morphologies of t-CPPD , m-CPPD, and o-CPPT is shown 
in Figure 7b using a sample taken from Study V, week 8, 
layer 4. 
Discussion 
Previous studies [13,15] have shown that ca+2 and 
PPi-4 ionic diffusion through a denatured collagen matrix at 
physiologic pH could reproducibly yield the two crystals 
observed in vivo in CPPD crystal deposition disease . This 
study is part of a series investigating the effect that other ions 
and crystals, which have been observed coincident with 
CPPD crystal deposition disease, have on CPPD crystal 
growth kinetics . The current study focuses on the 
perturbing effects that ferrous and ferric ions have on CPPD 
crystal growth kinetics. 
Ferric and, to some extent , ferrous ions blocked the 
progression of the ppj-4 diffusion gradient. This retardation 
in the [PPi- 4] gradient led to numerous changes in the 
kinetics of CPPD crystal formation. At the initial stages of 
crystal growth, the iron ions induced more crystal growth 
Effect of Soluble Iron on CPPD Crystal Growth 
Table 3: Hydroxyproline content of selected crystalline samples. Crystals were dissolved, hydroxyproline concentrations 
determined on the entire sample, and then the calcium concentrations quantitated in the assay solutions. In order to 
normalize the amount of hydroxyproline per crystalline mass, the concentration of hydroxyproline (ng/rnl) was divided by 
[Ca+2] (mM). 
Day Layer Hydroxyproline Ca+ 2 ni:/ml Crystal 
ng/ml 
STUDY I 7 4 880 
(Control) 56 7 0 
STUDY II 14 4 5640 
(FeCl3) 56 4-5 42 
56 6 49 
STUDY III 6 4 429 
(Control) 125 4 
STUDY IV 4 4 
(FeCl3) 97 4 
STUDY V 6 4 
(FeCh) 55 3 
compared to control. At later incubation times, the iron ions 
enhanced crystal growth at the expense of crystal nucleation. 
The presence of both ferrous and ferric ions resulted in the 
more rapid formation of t-CPPD and m-CPPD crystals . In 
solution studies, ferric ions also were found to lower the 
[PPi- 4] concentration which is required for CPPD crystal 
growth to one quarter that required in the absence of iron 
[8]. In the denatured co llagen matrix, the iron ions also 
reduced the solubility of the crystalline material in the broad 
diffuse bands which formed when the ca+2 and PPi-4 
gradients first met. This finding is consistent with 
McCarty's study on the clearance of preformed, radiolabeled 
t-CPPD crystals from rabbit joints [ 17]. They found that 
synovial hemosiderosis resulted in a 50% increase in the 
clearance time of the crystals. McCarty, et.al., hypothesized 
that the decreased clearance rate of t-CPPD crystals was due 
to ferrous ion inhibition of one or more intracellular 
pyrophosphatases. The current study suggests that , in 
addition to this enzyme inhibition, iron ions may also 
stabilize CPPD crystals against dissolution. 
In this in vitro system, the presence of either ferrous 
or ferric ions increased the amount of collagen 
(hydroxyproline) occluded in the crystalline precipitates 
formed at later times . At higher levels of ferric ion, iron is 
also incorporated into the crystals, particularly t-CPPD and 
m-CPPD. Finally, the presence of iron ions in this in vitro 
system resulted in the rare observation of the in. vivo crystal 
growth morphology of t-CPPD. This observation is totally 
absent from both control Studies I and III. 
The results of this in vitro study suggest that in 
biological grade gelatin, iron ions probably bind to the 
denatured collagen, PPi- 4 ions bind to the bound iron, 
leading to CPPD crystallization. This would account for the 
blockage of the PPi-4 gradient, and the occlusion of both 
collagen and iron within the crystals. The collagen/iron 
complex apparently leads to the more rapid formation oft-
CPPD and m-CPPD crystals in comparison to controls, and 
at later time points stabilizes the CPPD crystals against 
dissolution. A possible extrapolation to the in vivo setting is 
that the presence of iron ions surrounding chondrocytes 







mM mM Type 
3.12 282 0 
1.62 0 tmo 
24.33 232 trn 
10.83 4 tmo 
6.47 7 0 
6.36 67 0 
7.51 0 tmo 
7 35 0 
3.13 5 trno 
6.50 69 0 
4 19 tmo 
leading to an increased local [PPi-4], and thereby could 
create an environment favoring CPPD crystal formation. 
Several mechanisms have been proposed to explain 
the association of hemochromatosis and other iron 
deposition diseases and CPPD crystal deposition . These 
include changes in synoviocytes, chondrocytes, and cartilage 
matrix induced by iron . This study shows that ionic iron 
alone is sufficient to accelerate CPPD crystallization and to 
stabilize these crystals once formed . The importance of this 
finding to in vivo mechnisms of CPPD crystallization 
remains unknown . 
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Djscussjon with Reviewers 
R.Z. LeGeros: What is the level of ferrous and ferric ions 
in diseased states in biological systems? 
Authors: In idiopathic hemochromatosis, iron levels have 
been determined to be 0.019 mg/gm wet weight in synovium 
and 0.006 mg/gm wet weight in articular cartilage. 
Comparable data for control patients are 0 .013 mg/gm and 
0.004 mg/gm, respectively (Hamilton, et al. 1968) 
R. Terkeltaub: This model system, as the authors 
acknowledge, does represent merely a model system. 
Cartilage is comprised not only of collagen, but of course 
proteogylcans, cells and a number of proteins whose nature 
is presently under intense evaluation in a number of 
laboratories. It is intriguing that in the authors model system 
forms of CPPD crystals are generated which are similar to 
those deposited in vivo ir. cartilage. What specific 
information do the authors have on the effect of 
proteoglycans on CPPD crystal deposition in this model 
system? 
Authors: At the present time , we have not investigated the 
effect of proteoglycan on CPPD crystal growth in this 
system. This is clearly a very important and relevant effect 
which we are planning to investigate in the near future. 
R. Tawashj: It is surprising that Fe+3 and Fe+2 induced 
more crystal growth. These additives are believed at least to 
change the rheological characteristics of the gel. The gel 
permeability is reduced because of the consolidation of the 
gel. I wonder how the authors can rule out the effect of gel 
permeability and crystal poisoning by iron in the process of 
nucleation and growth? 
Authors: Comparison of Figures 2 with 1 and 5a and 6a 
with 4a shows that the calcium ion gradients are not 
significantly changed by the presence of either Fe+2 or 
Fe+3, suggesting that gel permeability was not altered 
significantly . The data presented here indicate that ionic iron 
initially enhanced crystal nucleation and then, at later times, 
enhanced crystal growth at the expense of crystal nucleation . 
These observations are not consistent with crystal poisoning 
by iron . 
R,Jawashj: In Figure 7, growth morphology shows very 
little . Crystals were grown for different periods of time and 
taken from different layers of the gel. 
Authors: We have looked at the crystal growth 
morphologies of many other layers and chosen to publish 
these because they were representative of the morphologies 
which we did see in other times and layers. 
